Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population

Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia

(2016) Farhana Sultana et al.   INTERNATIONAL JOURNAL OF CANCER

Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France

(2016) Catherine Tamalet et al.   JOURNAL OF CLINICAL VIROLOGY

Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program

(2015) M. Arbyn et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials

(2015) F. Verdoodt et al.   EUROPEAN JOURNAL OF CANCER

Cervical cancer screening in Europe: Quality assurance and organisation of programmes

(2015) K. Miriam Elfström et al.   EUROPEAN JOURNAL OF CANCER

Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening

(2015) Warner K. Huh et al.   OBSTETRICS AND GYNECOLOGY

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology

(2015) Theodoros Agorastos et al.   PLoS One

Epidemiology of HPV infection and current status of cervical cancer prevention in Greece

(2014) Theodoros Agorastos et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

(2014) Marc Arbyn et al.   LANCET ONCOLOGY

Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women

(2013) Eduardo Lazcano-Ponce et al.   INTERNATIONAL JOURNAL OF CANCER

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program

(2011) Murat Gök et al.   INTERNATIONAL JOURNAL OF CANCER

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Declining Death Rates Reflect Progress against Cancer

(2010) Ahmedin Jemal et al.   PLoS One

Cervical cancer screening policies and coverage in Europe

(2009) Ahti Anttila et al.   EUROPEAN JOURNAL OF CANCER

Prevalence and distribution of high-risk human papillomavirus in Greece

(2009) Theodoros Agorastos et al.   EUROPEAN JOURNAL OF CANCER PREVENTION